4 | SEC Filings Hub

Filing metadata

Accession number: 0001104659-22-098289
Form type: Form 4
Filer: Nabriva Therapeutics plc
CIK: CIK 1641640
Filed: Sep 07, 2022
Reporting period: Sep 06, 2022
Description: Insider transaction

Documents

0001104659-22-098289-index.htm

Complete submission

0001104659-22-098289.txt

directory listing

Filed by

Nabriva Therapeutics plc